Ocular adverse drug reaction images
Go to drug eruptions topic page
Severe blepharoconjunctivitis that arose within 8 weeks of dupilumab introduction (OADR-patient1)
Severe blepharoconjunctivitis that arose within 8 weeks of dupilumab introduction (OADR-patient1)
Severe blepharoconjunctivitis that arose within 8 weeks of dupilumab introduction (OADR-patient1)
Go to drug eruptions topic page
